Form 13-F position report

LEXARIA BIOSCIENCE CORP

Reported by RAYMOND JAMES FINANCIAL INC

LEXX CUSIP 52886N406 Manager CIK 0000720005

First reported at 60,640 shares this quarter.

New
% of reported 13F value < 0.01% This manager · Q4 2024
Shares 60,640 Quarter-end amount reported
Reported value $127,344 Fair value at quarter end
Consecutive quarters held 1 Through Q4 2024

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2024-12-31 127344
2025-03-31 104738
2025-06-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

3 quarters
Quarterly reported position history for LEXARIA BIOSCIENCE CORP held by RAYMOND JAMES FINANCIAL INC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2025 Reduced 0 -61,250 (-100.0%) 0 $0 2025-08-14
Q1 2025 Added 61,250 +610 (1.0%) < 0.01% $104,738 2025-05-13
Q4 2024 New 60,640 +60,640 (0.0%) < 0.01% $127,344 2025-02-06

Who else reported the position

32 managers reported LEXARIA BIOSCIENCE CORP for Q4 2024.

Managers reporting LEXARIA BIOSCIENCE CORP in Q4 2024.
Manager Activity Shares Change % of reported 13F Reported value Tenure
ARMISTICE CAPITAL LLC New 460,000 +460,000 0.01% $966,000 3 qtrs
Invenomic Capital Management LP Reduced 410,731 -65,042 0.04% $862,535 16 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 166,679 +16,288 < 0.01% $350,112 15 qtrs
VANGUARD GROUP INC Added 127,433 +18,411 < 0.01% $267,609 15 qtrs
RAYMOND JAMES FINANCIAL INC This report New 60,640 +60,640 < 0.01% $127,344 1 qtr
STATE STREET CORPORATION Unchanged 39,301 0 < 0.01% $82,532 4 qtrs
WEALTH ENHANCEMENT ADVISORY SERVICES LLC Added 28,873 +15,050 < 0.01% $60,633 4 qtrs
BlackRock Inc Unchanged 27,445 0 < 0.01% $57,635 2 qtrs
HighTower Advisors LLC Added 21,023 +8,000 < 0.01% $44,148 2 qtrs
MORGAN STANLEY Reduced 20,229 -2,753 < 0.01% $42,481 4 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
December 31, 2024
Filed
February 06, 2025
Filing type
13F-HR
Position type
COM NEW

Voting authority reported

Sole
0
Shared
0
None
60,640

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.